Clinical Trial Update: The Clinical Efficacy and Safety of Iguratimod in RA and Early RA Patients for 6 Months Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy and safety of iguratimod in rheumatoid arthritis and early rheumatoid arthritis over 6 months.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Iguratimod (iguratimod)

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: COMPLETED